亿帆医药
(002019)
| 流通市值:75.15亿 | | | 总市值:108.50亿 |
| 流通股本:8.43亿 | | | 总股本:12.16亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 3,721,524,853.47 | 2,467,572,376.09 | 1,255,507,032.81 | 5,132,949,329.53 |
| 营业总成本 | 3,331,987,570.65 | 2,194,461,836.94 | 1,119,394,963.51 | 4,696,113,393.72 |
| 其他经营收益 | | | | |
| 营业利润 | 335,440,494.39 | 230,346,682.79 | 120,067,266.08 | 428,644,889.8 |
| 利润总额 | 333,932,340.66 | 229,282,142.47 | 120,862,479.85 | 423,704,237.46 |
| 净利润 | 259,799,594.38 | 187,392,598.33 | 95,712,723.84 | 373,451,729.24 |
| 每股收益 | | | | |
| 其他综合收益 | -72,048,788.87 | -70,765,756.86 | -45,377,158.2 | 29,928,782.62 |
| 综合收益总额 | 187,750,805.51 | 116,626,841.47 | 50,335,565.64 | 403,380,511.86 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 4,088,599,654.39 | 3,894,048,820.13 | 3,867,192,019.03 | 3,921,887,791.24 |
| 非流动资产: | | | | |
| 非流动资产合计 | 9,110,629,679.71 | 8,993,618,901.51 | 8,978,072,598.73 | 8,923,116,422.45 |
| 资产总计 | 13,199,229,334.1 | 12,887,667,721.64 | 12,845,264,617.76 | 12,845,004,213.69 |
| 流动负债: | | | | |
| 流动负债合计 | 2,661,827,199.86 | 3,019,540,439.53 | 2,891,988,690.22 | 3,033,045,515.32 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,828,065,344.59 | 1,181,621,881.85 | 1,192,314,763.15 | 1,100,973,007.83 |
| 负债合计 | 4,489,892,544.45 | 4,201,162,321.38 | 4,084,303,453.37 | 4,134,018,523.15 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 8,887,473,287.02 | 8,847,213,570.27 | 8,895,654,773.76 | 8,834,531,174.79 |
| 股东权益合计 | 8,709,336,789.65 | 8,686,505,400.26 | 8,760,961,164.39 | 8,710,985,690.54 |
| 负债和股东权益合计 | 13,199,229,334.1 | 12,887,667,721.64 | 12,845,264,617.76 | 12,845,004,213.69 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 4,168,008,117.26 | 2,665,960,465.25 | 1,367,875,704.74 | 5,356,115,263.58 |
| 经营活动现金流出小计 | 3,734,292,942.98 | 2,072,450,401.11 | 1,083,037,487 | 4,897,748,978.75 |
| 经营活动产生的现金流量净额 | 433,715,174.28 | 593,510,064.14 | 284,838,217.74 | 458,366,284.83 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 64,336,644.03 | 62,064,427.99 | 8,999,530.41 | 105,137,190.17 |
| 投资活动现金流出小计 | 661,042,739.96 | 427,167,958.5 | 215,715,287.35 | 559,232,140.2 |
| 投资活动产生的现金流量净额 | -596,706,095.93 | -365,103,530.51 | -206,715,756.94 | -454,094,950.03 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 2,037,180,314.9 | 716,542,199.26 | 361,846,346.49 | 1,857,956,837.59 |
| 筹资活动现金流出小计 | 1,672,431,382 | 774,773,590.83 | 359,029,848.98 | 1,972,128,315.4 |
| 筹资活动产生的现金流量净额 | 364,748,932.9 | -58,231,391.57 | 2,816,497.51 | -114,171,477.81 |
| 汇率变动对现金及现金等价物的影响 | -14,049,796.84 | -24,481,532.3 | -14,429,757.72 | -3,969,598.42 |
| 现金及现金等价物净增加额 | 187,708,214.41 | 145,693,609.76 | 66,509,200.59 | -113,869,741.43 |
| 期末现金及现金等价物余额 | 851,476,330.88 | 809,461,726.23 | 730,277,317.06 | 663,768,116.47 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 145,693,609.76 | - | -113,869,741.43 |
最新报告期:2026-11-05| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 上海证券 | 张林晚 | 0.34 | 0.38 | 0.42 | 2026-11-05 |
| 华安证券 | 谭国超 | 0.36 | 0.46 | 0.53 | 2026-11-05 |
| 西南证券 | 杜向阳 | 0.37 | 0.44 | 0.50 | 2026-10-26 |
| 天风证券 | 杨松,曹文清 | 0.35 | 0.44 | 0.54 | 2026-09-30 |
| 首创证券 | 王斌 | 0.35 | 0.44 | 0.52 | 2026-09-21 |